{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:48:20Z","timestamp":1768783700763,"version":"3.49.0"},"reference-count":27,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The aim of the present study is to elucidate the mechanism of CYP2E1 induction\nas a causative factor of alcoholic hepatitis (AH) and its relationship with inflammation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Chronic alcohol consumption induces CYP2E1, which is involved in the development\nof alcoholic hepatitis (AH). However, the mechanisms underlying the induction of CYP2E1\nby alcohol remain unclear. Therefore, we herein investigated the induction of drug-metabolizing\nenzymes, particularly CYP2E1, by hydrogen peroxide (H2O2), the concentration of which is elevated\nunder inflammatory conditions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The mechanisms underlying the induction of CYP2E1 by H2O2 were examined with a\nfocus on Keap1, a target factor of H2O2.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We assessed changes in the expression of drug-metabolizing enzymes in the human\nhepatoma cell line, Hep3B, following treatment with H2O2, and evaluated changes in the expression\nof the NFkB-related factor RelA(p65) after the knockdown of Keap1, a regulator of Nrf2\nexpression by reactive oxygen species. We also performed a promoter analysis using the upstream\nregion of the CYP2E1 gene. We herein used the GSE89632 series for non-alcoholic hepatitis\n(NASH) and the GSE28619 series for AH.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The induction of CYP2E1 by H2O2 was significantly stronger than that of other drugmetabolizing\nenzymes. On the other hand, the knockdown of Keap1, a target of H2O2, markedly\nincreased RelA(p65), an NFkB factor. Furthermore, the overexpression of RelA(p65) strongly\ninduced the expression of CYP2E1. Four candidate p65-binding sequences were identified upstream\nof the CYP2E1 gene, and promoter activity assays showed that the third sequence was\nresponsive to the overexpression of RelA(p65). We used the GSE89632 series for NASH and the\nGSE28619 series for AH in the present study. The expression of CYP2E1 mRNA in the liver was\nsignificantly lower in AH patients than in HC patients, but was similar in HC patients and NASH\npatients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>We herein demonstrated that the expression of CYP2E1 was induced by H2O2. The\noverexpression of RelA(p65) also induced CYP2E1 mRNA expression, whereas H2O2 did not\nafter the knockdown of RelA. These results suggest that H2O2 acts on Keap1 to upregulate RelA\n(p65) in the NFkB system. One of the mechanisms underlying the induction of CYP2E1 was dependent\non the H2O2-Keap1-RelA axis. The results of the database analysis revealed that the expression\nof CYP2E1 in the liver was significantly lower in AHH patients than in NASH patients,\nsuggesting that CYP2E1 is not the main cause of AH; however, CYP2E1 may exacerbate the\npathogenesis of AH.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892002305174240805064406","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T06:06:38Z","timestamp":1723442798000},"page":"307-316","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hydrogen Peroxide Induces Ethanol-inducible CYP2E1 via the NF-kB-classical Pathway: CYP2E1 mRNA Levels are not High in Alcoholic Hepatitis"],"prefix":"10.2174","volume":"25","author":[{"given":"Akiyoshi","family":"Tamura","sequence":"first","affiliation":[{"name":"Department of Biomedical Chemistry, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-1514","authenticated-orcid":true,"given":"Ferbian","family":"Milas Siswanto","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia,\nJakarta, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Biomedical Chemistry, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3461-1259","authenticated-orcid":true,"given":"Ami","family":"Oguro","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4350-2337","authenticated-orcid":true,"given":"Susumu","family":"Imaoka","sequence":"additional","affiliation":[{"name":"Department of Biomedical Chemistry, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/bj3470321","volume":"347","author":"Honkakoski P.","year":"2000","unstructured":"Honkakoski P.; Negishi M.; Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J  2000,347(2),321-337","journal-title":"Biochem J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1159\/000324289","volume":"28","author":"Cederbaum A.I.","year":"2010","unstructured":"Cederbaum A.I.; Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig Dis  2010,28(6),802-811","journal-title":"Dig Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.3390\/ijms22158221","volume":"22","author":"Harjum\u00e4ki R.","year":"2021","unstructured":"Harjum\u00e4ki R.; Pridgeon C.S.; Ingelman-Sundberg M.; CYP2E1 in alcoholic and non-alcoholic liver injury. Roles of ros, reactive intermediates and lipid overload. Int J Mol Sci  2021,22(15),8221","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"Suzuki T.","year":"2015","unstructured":"Suzuki T.; Yamamoto M.; Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med  2015,88(Pt B),93-100","journal-title":"Free Radic Biol Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.dmpk.2020.06.007","volume":"35","author":"Siswanto F.M.","year":"2020","unstructured":"Siswanto F.M.; Oguro A.; Arase S.; Imaoka S.; WDR23 regulates the expression of Nrf2-driven drug-metabolizing enzymes. Drug Metab Pharmacokinet  2020,35(5),441-455","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/cr.2010.161","volume":"21","author":"Shih V.F.","year":"2011","unstructured":"Shih V.F.; Tsui R.; Caldwell A.; Hoffmann A.; A single NF\u03baB system for both canonical and non-canonical signaling. Cell Res  2011,21(1),86-102","journal-title":"Cell Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"Gilmore T.D.","year":"2006","unstructured":"Gilmore T.D.; Introduction to NF-\u03baB: Players, pathways, perspectives. Oncogene  2006,25(51),6680-6684","journal-title":"Oncogene"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1006\/bbrc.1998.9232","volume":"249","author":"Hiroi T.","year":"1998","unstructured":"Hiroi T.; Imaoka S.; Funae Y.; Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun  1998,249(3),838-843","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/0113892002271342231013095255","volume":"24","author":"Siswanto F.M.","year":"2023","unstructured":"Siswanto F.M.; Handayani M.D.N.; Firmasyah R.D.; Oguro A.; Imaoka S.; Nrf2 regulates the expression of CYP2D6 by inhibiting the activity of Kr\u00fcppel-Like Factor 9 (KLF9). Curr Drug Metab  2023,24(9),667-681","journal-title":"Curr Drug Metab"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"21265","DOI":"10.1038\/s41598-022-25784-0","volume":"12","author":"Siswanto F.M.","year":"2022","unstructured":"Siswanto F.M.; Mitsuoka Y.; Nakamura M.; Oguro A.; Imaoka S.; Nrf2 and Parkin-Hsc70 regulate the expression and protein stability of p62\/SQSTM1 under hypoxia. Sci Rep  2022,12(1),21265","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/10715762.2023.2229509","volume":"57","author":"Siswanto F.M.","year":"2023","unstructured":"Siswanto F.M.; Okukawa K.; Tamura A.; Oguro A.; Imaoka S.; Hydrogen peroxide activates APE1\/Ref-1 via NF-\u03baB and Parkin: A role in liver cancer resistance to oxidative stress. Free Radic Res  2023,57(3),223-238","journal-title":"Free Radic Res"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100704","volume":"296","author":"Siswanto F.M.","year":"2021","unstructured":"Siswanto F.M.; Oguro A.; Imaoka S.; Sp1 is a substrate of Keap1 and regulates the activity of CRL4AWDR23 ubiquitin ligase toward Nrf2. J Biol Chem  2021,296","journal-title":"J Biol Chem"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108918","volume":"316","author":"Seitz H.K.","year":"2020","unstructured":"Seitz H.K.; The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis. Chem Biol Interact  2020,316","journal-title":"Chem Biol Interact"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","volume":"23","author":"Yu M.","year":"2011","unstructured":"Yu M.; Li H.; Liu Q.; Liu F.; Tang L.; Li C.; Yuan Y.; Zhan Y.; Xu W.; Li W.; Chen H.; Ge C.; Wang J.; Yang X.; Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signal  2011,23(5),883-892","journal-title":"Cell Signal"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.bcp.2004.06.003","volume":"68","author":"Abdel-Razzak Z.","year":"2004","unstructured":"Abdel-Razzak Z.; Garlatti M.; Aggerbeck M.; Barouki R.; Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter. Biochem Pharmacol  2004,68(7),1371-1381","journal-title":"Biochem Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1006\/abbi.2000.2001","volume":"382","author":"Peng H.M.","year":"2000","unstructured":"Peng H.M.; Coon M.J.; Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2. Arch Biochem Biophys  2000,382(1),129-137","journal-title":"Arch Biochem Biophys"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225531","volume":"14","author":"Lin Q.","year":"2019","unstructured":"Lin Q.; Kang X.; Li X.; Wang T.; Liu F.; Jia J.; Jin Z.; Xue Y.; NF-\u03baB-mediated regulation of rat CYP2E1 by two independent signaling pathways. PLoS One  2019,14(12)","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0300-483X(96)03475-0","volume":"114","author":"Sindhu R.K.","year":"1996","unstructured":"Sindhu R.K.; Sakai H.; Okamoto T.; Kikkawa Y.; Differential effect of interleukin-1\u03b1 on rat hepatic cytochrome P450 monooxygenases. Toxicology  1996,114(1),37-46","journal-title":"Toxicology"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/S0022-2275(20)32422-6","volume":"40","author":"Adas F.","year":"1999","unstructured":"Adas F.; Sala\u00fcn J.P.; Berthou F.; Picart D.; Simon B.; Amet Y.; Requirement for \u03c9 and (\u03c9\u20131)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J Lipid Res  1999,40(11),1990-1997","journal-title":"J Lipid Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1194\/jlr.M022319","volume":"53","author":"Oguro A.","year":"2012","unstructured":"Oguro A.; Imaoka S.; Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase. J Lipid Res  2012,53(3),505-512","journal-title":"J Lipid Res"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109056","volume":"322","author":"Guengerich F.P.","year":"2020","unstructured":"Guengerich F.P.; Cytochrome P450 2E1 and its roles in disease. Chem Biol Interact  2020,322","journal-title":"Chem Biol Interact"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"121375","DOI":"10.1016\/j.lfs.2023.121375","volume":"315","author":"Kotwal P.","year":"2023","unstructured":"Kotwal P.; Khajuria P.; Dhiman S.; Kour D.; Dhiman S.K.; Kumar A.; Nandi U.; Molecular mechanism for the involvement of CYP2E1\/NF-\u03baB axis in bedaquiline-induced hepatotoxicity. Life Sci  2023,315,121375","journal-title":"Life Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.M110.176685","volume":"286","author":"Wang Y.","year":"2011","unstructured":"Wang Y.; Guan S.; Acharya P.; Koop D.R.; Liu Y.; Liao M.; Burlingame A.L.; Correia M.A.; Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: Identification of sites targeted for phosphorylation and ubiquitination. J Biol Chem  2011,286(11),9443-9456","journal-title":"J Biol Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/jhep.2002.33720","volume":"36","author":"Morgan K.","year":"2002","unstructured":"Morgan K.; French S.W.; Morgan T.R.; Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology  2002,36(1),122-134","journal-title":"Hepatology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jhep.2008.10.020","volume":"50","author":"Butura A.","year":"2009","unstructured":"Butura A.; Nilsson K.; Morgan K.; Morgan T.R.; French S.W.; Johansson I.; Schuppe-Koistinen I.; Ingelman-Sundberg M.; The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol  2009,50(3),572-583","journal-title":"J Hepatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2003.09.009","volume":"203","author":"Imaoka S.","year":"2004","unstructured":"Imaoka S.; Osada M.; Minamiyama Y.; Yukimura T.; Toyokuni S.; Takemura S.; Hiroi T.; Funae Y.; Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett  2004,203(2),117-125","journal-title":"Cancer Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.freeradbiomed.2004.05.022","volume":"37","author":"Minamiyama Y.","year":"2004","unstructured":"Minamiyama Y.; Takemura S.; Toyokuni S.; Imaoka S.; Funae Y.; Hirohashi K.; Yoshikawa T.; Okada S.; CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. Free Radic Biol Med  2004,37(5),703-712","journal-title":"Free Radic Biol Med"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002305174240805064406","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/232786\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002305174240805064406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T06:23:13Z","timestamp":1730874193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/232786\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892002305174240805064406","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}